Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Prospective Outpatient Registry of Myocardial Infarction Patients
A completed prospective outpatient registry study involving patients with myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Near-infrared Spectroscopy Guided Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction [NA]
Completed clinical trial evaluating near-infrared spectroscopy-guided percutaneous coronary intervention in patients with acute myocardial i…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Optimize Risk Prediction After Myocardial Infarction: The ORACLE Study
The ORACLE study is a clinical trial aimed at improving risk prediction after myocardial infarction and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction [Phase 4]
A Phase 4 Danish clinical trial evaluating beta-blocker therapy after myocardial infarction in patients without reduced ejection fraction; t…
-
CLINICAL_TRIALS withdrawal · 2025-06-08Clinical Trial Update: Hyperoxemic Oxygen Therapy in Patients With Acute Anterior Myocardial Infarction [NA]
A clinical trial evaluating hyperoxemic oxygen therapy in patients with acute anterior myocardial infarction has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Biomarkers in Patients Hospitalized With Suspected Acute Myocardial Infarction
This update summarizes the completed clinical trial investigating biomarkers in patients hospitalized with suspected acute myocardial infarc…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function [Phase 4]
Phase 4 clinical trial update on BEtablocker as treatment after acute myocardial infarction in patients without reduced left ventricular fun…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion" [Phase 4]
Phase 4 trial evaluating the use of beta-blockers after myocardial infarction with preserved ejection fraction; study status is completed.
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Efferon CT Hemoadsorption for Cardiogenic Shock in Acute Myocardial Infarction [NA]
A clinical trial evaluating Efferon CT hemoadsorption for cardiogenic shock in patients with acute myocardial infarction is currently recrui…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI [EARLY_Phase 1]
Early-phase trial entry describing multimodality cardiovascular imaging to support translation of vascular activation therapies after myocar…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Development of a Novel Risk Prediction Tool for Emergency Department Patients Symptoms of Coronary Artery Disease
A clinical study is developing a novel risk prediction tool for emergency department patients with symptoms of coronary artery disease; the …
-
CLINICAL_TRIALS research · 2025-06-02Clinical Trial Update: The RECOVERY Study: Using Supersaturated Oxygen Therapy To Treat Small Vessel Blockages After a Heart Attack [NA]
The RECOVERY Study is evaluating supersaturated oxygen therapy to treat small vessel blockages after a heart attack; the trial is active but…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction [Phase 3]
A Phase 3 trial evaluated whether implantable cardioverter-defibrillator therapy reduces sudden death after a myocardial infarction and has …
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Timing of FFR-guided PCI for Non-IRA in STEMI and MVD (OPTION-STEMI) [NA]
Clinical trial OPTION-STEMI examining timing of FFR-guided PCI for non-infarct-related arteries in STEMI with multivessel disease; the study…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Wearable Devices Faciliate the Management of AMI Patients
Clinical trial is evaluating wearable devices to facilitate the management of patients with acute myocardial infarction and is currently in …
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Fibrosis Assessment in Myocardial Infarction-associated Ventricular Aneurysm
RenJi Hospital is recruiting a study to assess myocardial fibrosis in patients with ventricular aneurysm following an acute myocardial infar…
-
CLINICAL_TRIALS other · 2025-05-27Clinical Trial Update: the Impact of Transcutaneous Vagus Nerve Stimulation on Cardiovascular Events in Patients With Acute Myocardial Infarction [NA]
A clinical trial is investigating whether transcutaneous vagus nerve stimulation can reduce cardiovascular events in patients with acute myo…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Secondary Prevention of Cardiovascular Disease in the Elderly Trial [Phase 3]
Phase 3 trial evaluating secondary prevention of cardiovascular disease in the elderly has completed and posted results.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: A Randomized, Single-blind, Controlled Clinical Study of Cardiomyopeptidin on Improving Ischemia-reperfusion Injury in Patients With Acute ST-segment Elevation Myocardial Infarction After Primary PCI [Phase 4]
Phase 4 randomized, single-blind trial evaluating Cardiomyopeptidin for reducing ischemia-reperfusion injury in patients with ST-segment ele…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer
This entry describes an ongoing clinical trial evaluating the risk of cardiovascular adverse events related to immune checkpoint inhibitors …
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis [NA]
A clinical trial update describes testing sirolimus with corticosteroid therapy to address rapid recurrences of coronary unexplained in-sten…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Impact of Early PCSK9 Inhibitor on Heart After Acute Myocardium Infarction [Phase 4]
A Phase 4 clinical trial is recruiting to evaluate whether early administration of a PCSK9 inhibitor after acute myocardial infarction affec…
-
EMA approval · 2025-05-14EMA Authorised: Clopidogrel Krka (clopidogrel (as hydrochloride)) — Krka, d.d., Novo mesto
EMA authorised Clopidogrel Krka (clopidogrel hydrochloride) on 14 May 2025 for reducing cardiovascular events in patients with peripheral ar…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: SpinChip Hs-cTnI Multisite Precision
Clinical trial update indicates the multisite study evaluating SpinChip Diagnostics ASA's high-sensitivity troponin I assay for acute myocar…
-
EMA approval · 2025-05-14EMA Authorised: Zyllt (clopidogrel (as hydrogen sulfate)) — Krka, d.d., Novo mesto
EMA authorised Zyllt, a clopidogrel hydrogen sulfate product by Krka, d.d., Novo mesto. It is indicated for preventing vascular events in pa…